Clementia Pharmaceuticals Overview
- Year Founded
-
2010
- Status
-
Acquired/Merged
- Employees
-
45
- Latest Deal Type
-
M&A
- Financing Rounds
-
8
Clementia Pharmaceuticals General Information
Description
Operator of a biopharmaceutical company intended for developing disease-modifying treatments for patients suffering from debilitating bone and other diseases with high unmet medical needs. The company's lead product candidate, palovarotene, is an oral small molecule that has shown potent activity in preventing abnormal new bone formation as well as fibrosis in a variety of tissues.
Contact Information
Website
www.clementiapharma.comCorporate Office
- 4150 Ste-Catherine Street West
- Suite 550
- Montreal, Quebec H3Z 2Y5
- Canada
Corporate Office
- 4150 Ste-Catherine Street West
- Suite 550
- Montreal, Quebec H3Z 2Y5
- Canada
Clementia Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Clementia Pharmaceuticals Comparisons
Industry
Financing
Details
Clementia Pharmaceuticals Competitors (105)
One of Clementia Pharmaceuticals’s 105 competitors is Orchard Therapeutics, a Formerly VC-backed company based in London, United Kingdom.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Orchard Therapeutics | Formerly VC-backed | London, United Kingdom | ||||
| Phathom Pharmaceuticals | Formerly VC-backed | Florham Park, NJ | ||||
| Inovio Pharmaceuticals | Corporation | Plymouth Meeting, PA | ||||
| Lexeo Therapeutics | Formerly VC-backed | New York, NY | ||||
| Gamida Cell | Formerly VC-backed | Boston, MA |
Clementia Pharmaceuticals Patents
Clementia Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026213691-A1 | Methods for treating fibrodysplasia ossificans progressiva | Pending | 08-Apr-2025 | ||
| WO-2026213693-A1 | Methods for treating fibrodysplasia ossificans progressiva | Pending | 08-Apr-2025 | ||
| EP-3893880-A1 | Methods for treating heterotopic ossification | Inactive | 13-Dec-2018 | ||
| EP-3893880-A4 | Methods for treating heterotopic ossification | Inactive | 13-Dec-2018 | ||
| US-20220054487-A1 | Methods for treating heterotopic ossification | Inactive | 13-Dec-2018 | A61K31/415 |
Clementia Pharmaceuticals Signals
Clementia Pharmaceuticals Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Clementia Pharmaceuticals FAQs
-
When was Clementia Pharmaceuticals founded?
Clementia Pharmaceuticals was founded in 2010.
-
Where is Clementia Pharmaceuticals headquartered?
Clementia Pharmaceuticals is headquartered in Montreal, Canada.
-
What is the size of Clementia Pharmaceuticals?
Clementia Pharmaceuticals has 45 total employees.
-
What industry is Clementia Pharmaceuticals in?
Clementia Pharmaceuticals’s primary industry is Drug Discovery.
-
Is Clementia Pharmaceuticals a private or public company?
Clementia Pharmaceuticals is a Private company.
-
What is the current valuation of Clementia Pharmaceuticals?
The current valuation of Clementia Pharmaceuticals is .
-
What is Clementia Pharmaceuticals’s current revenue?
The current revenue for Clementia Pharmaceuticals is .
-
How much funding has Clementia Pharmaceuticals raised over time?
Clementia Pharmaceuticals has raised $236M.
-
Who are Clementia Pharmaceuticals’s investors?
Amplitude Ventures, BDC Capital, EcoR1 Capital, Fonds de solidarite FTQ, and Janus Capital Group are 5 of 11 investors who have invested in Clementia Pharmaceuticals.
-
Who are Clementia Pharmaceuticals’s competitors?
Orchard Therapeutics, Phathom Pharmaceuticals, Inovio Pharmaceuticals, Lexeo Therapeutics, and Gamida Cell are some of the 105 competitors of Clementia Pharmaceuticals.
-
When was Clementia Pharmaceuticals acquired?
Clementia Pharmaceuticals was acquired on 18-Apr-2019.
-
Who acquired Clementia Pharmaceuticals?
Clementia Pharmaceuticals was acquired by Ipsen.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process